Effect of the beta-receptor blocker propranolol on the catecholamin level and dopamin-beta-hydroxylase in patients with essential hypertension
Planz, G.; Planz, R.; Gierlichs, H.W.; Rahn, K.H.
Die Medizinische Welt 29(9): 366-367
1978
ISSN/ISBN: 0025-8512 PMID: 634138 Document Number: 134075
Document emailed within 1 workday
Related Documents
Walter, I.; Kusus, T.; Wagner, K.; Lydtin, H. 1973: Effect of a beta receptor blocker on cardiac output--studies in essential hypertension and hyperkinetic heart syndrome with reference to plasma adrenaline and noradrenaline levels Verhandlungen der Deutschen Gesellschaft für Innere Medizin 79: 1010-1013Planz, G.; Corr, H.; Gierlichs, H.W.; Hawlina, A.; Planz, R.; Stephany, W.; Rahn, K.H. 1975: Dopamine-beta-hydroxylase activity and catecholamine concentration in plasma as a parameter of sympathetic tonus: effect of the ergometric test on patients with normotension and essential hypertension Verhandlungen der Deutschen Gesellschaft für Innere Medizin 81: 1066-1068
Markiewicz, M.; Jach, A.; Horubała-Bielak, G. 1978: Activity of dopamine beta-hydroxylase in the serum of patients with essential hypertension Polski Tygodnik Lekarski 33(27): 1057-1059
Löllgen, H.; Schmidt, A.; Upmeyer, H.J. 1986: Double-blind comparison of fixed combination preparations of a beta blocker and a diuretic and beta blocker, a diuretic and hydralazine in patients with coronary heart disease and arterial hypertension Medizinische Klinik 81(23): 745-750
Pietruschka, W.D.; Scheuch, K.; Gruber, G.; Tomaschewskaja, L.I.; Reuschel, I. 1981: Heart rate and blood pressure under psychological and physical laboratory stress in young hypertensive patients following long-term therapy with the beta receptor blocker propranolol Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 36(6): 218-222
Andrianova, I.V.; Rekhter, M.D.; Tertov, V.V.; Andreeva, E.R.; Mironov, A.A.; Orekhov, A.N. 1992: Elimination of the atherogenic effect of beta blocker propranolol by papaverine Biulleten' Eksperimental'noi Biologii i Meditsiny 113(3): 273-275
Lang, R. 1980: Balance of noradrenaline and sodium during chronic beta-receptor blockade in patients with essential hypertension Archives Internationales de Pharmacodynamie et de Therapie Suppl: 67-75
Rahn, K.H. 1980: The influence of beta receptor blocking drugs on plasma catecholamine levels in patients with essential hypertension Archives Internationales de Pharmacodynamie et de Therapie Suppl: 54-57
Sievert, H.; Schmidt, T.; Frey, G.; Schräder, R.; van der Does, R.; Kaltenbach, M.; Kober, G. 1991: Neither propranolol nor the vasodilating beta-blocker carvedilol have a direct effect on coronary resistance vessels Zeitschrift für Kardiologie 80(1): 15-19
Aoki, K.; Sato, K. 1982: Acute hypotensive, hemodynamic effects of long-term treatment with niludipine, a Ca2+-antagonist, in patients with essential hypertension. Niludipine monotherapy and combination with a beta-blocker and a diuretic) Arzneimittel-Forschung 32(9): 1141-1145
Thomas, J.A.; Sakai, K.K.; Holck, M.I.; Marks, B.H. 1980: Dopamine-beta-hydroxylase: a modulator of beta adrenergic receptor activity Research Communications in Chemical Pathology and Pharmacology 29(1): 3-13
England, J.D. 1981: Beta adrenoreceptor-blocking drugs once daily in essential hypertension: a comparison of propranolol, pindolol and atenolol Australian and New Zealand Journal of Medicine 11(1): 35-40
Matthys, H.; Doshan, H.D.; Rühle, K.H.; Applin, W.J.; Braig, H.; Pohl, M. 1986: Bronchosparing properties of celiprolol, a new beta 1, alpha 2-blocker, in propranolol-sensitive asthmatic patients Journal of Cardiovascular Pharmacology 8(Suppl 4): S40-S42
Przewlocka, B.; Sarnek, J.; Szmigielski, A.; Niewiadomska, A. 1975: The effect of some dithiocarbamic acids on dopamine-beta-hydroxylase and catecholamines level in rat's brain Polish Journal of Pharmacology and Pharmacy 27(5): 555-559
Kawanishi, D.T.; Reid, C.L.; Gonzales, A.; O'Rourke, R.A.; Rahimtoola, S.H. 1989: Response of blood pressure, cardiac output, peripheral resistance, and exercise performance to substitution of calcium blocker for beta-blocker plus thiazide diuretic therapy in patients with both systemic hypertension and mild stable angina Circulation 80(6 Suppl): Iv162-Iv170
Furberg, C.D.; Byington, R.P. 1983: What do subgroup analyses reveal about differential response to beta-blocker therapy? The Beta-Blocker Heart Attack Trial experience Circulation 67(6 Part 2): I98-101
Leshchinskiĭ, L.A.; Logacheva, I.V.; Nikolaeva, V.A.; Plastinina, R.A.; Polischuk, M.A. 1983: Effect of the combined administration of alpha- and beta-adrenergic blockaders (propranolol and phentolamine) on central and renal hemodynamics during the treatment of patients with arterial hypertension Terapevticheskii Arkhiv 55(9): 48-51
Shigetomi, S.; Hashimoto, S.; Fukuchi, S. 1982: The role of sympathetic beta-adrenergic receptor on renin secretion in essential hypertension Nihon Jinzo Gakkai Shi 24(8): 929-936
Mauser, M.; Voelker, W.; Ickrath, O.; Hoffmeister, H.M.; Karsch, K.R. 1989: The acute hemodynamic effects of the new vasodilating beta blocker carvedilol in comparison with combined administration of nifedipine and propranolol in patients with coronary heart disease Zeitschrift für Kardiologie 78(11): 726-731
Buranakitjaroen, P.; Phoojaroenchanachai, M.; Saravich, S.; Sangprasert, P. 2002: The efficacy and tolerability of an angiotensin Ii receptor blocker, telmisartan, in Thai patients with mild to moderate essential hypertension Journal of the Medical Association of Thailand 85(9): 968-977